DE1492154A1 - Verfahren zur Herstellung eines therapeutsich wertvollen Gemischs von silberhaltigen Komplexen und Chloriden - Google Patents
Verfahren zur Herstellung eines therapeutsich wertvollen Gemischs von silberhaltigen Komplexen und ChloridenInfo
- Publication number
- DE1492154A1 DE1492154A1 DE1962S0100894 DES0100894A DE1492154A1 DE 1492154 A1 DE1492154 A1 DE 1492154A1 DE 1962S0100894 DE1962S0100894 DE 1962S0100894 DE S0100894 A DES0100894 A DE S0100894A DE 1492154 A1 DE1492154 A1 DE 1492154A1
- Authority
- DE
- Germany
- Prior art keywords
- silver
- preparation
- chlorides
- therapeutically valuable
- containing complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims description 17
- 229910052709 silver Inorganic materials 0.000 title claims description 16
- 239000004332 silver Substances 0.000 title claims description 16
- 238000000034 method Methods 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 4
- 239000000203 mixture Substances 0.000 title description 6
- 150000001805 chlorine compounds Chemical class 0.000 title description 2
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 10
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 10
- 239000011541 reaction mixture Substances 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- ZSILVJLXKHGNPL-UHFFFAOYSA-L S(=S)(=O)([O-])[O-].[Ag+2] Chemical compound S(=S)(=O)([O-])[O-].[Ag+2] ZSILVJLXKHGNPL-UHFFFAOYSA-L 0.000 claims 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 claims 1
- 238000011282 treatment Methods 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007596 consolidation process Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UPGTYLFCVNHBTN-UHFFFAOYSA-N (20Z)-cholest-5,20(22)-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CCC(C)C)C1(C)CC2 UPGTYLFCVNHBTN-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- OYXZMSRRJOYLLO-UHFFFAOYSA-N 7alpha-Hydroxycholesterol Natural products OC1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 OYXZMSRRJOYLLO-UHFFFAOYSA-N 0.000 description 1
- OYXZMSRRJOYLLO-KGZHIOMZSA-N 7beta-hydroxycholesterol Chemical compound C([C@@H]1O)=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 OYXZMSRRJOYLLO-KGZHIOMZSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- UPGTYLFCVNHBTN-OFAYOZIESA-N cholesta-5,22E-dien-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/CC(C)C)[C@@]1(C)CC2 UPGTYLFCVNHBTN-OFAYOZIESA-N 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 210000004283 incisor Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 210000003456 pulmonary alveoli Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(I) nitrate Inorganic materials [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C05—FERTILISERS; MANUFACTURE THEREOF
- C05D—INORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C; FERTILISERS PRODUCING CARBON DIOXIDE
- C05D9/00—Other inorganic fertilisers
- C05D9/02—Other inorganic fertilisers containing trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR69041127A FR882M (OSRAM) | 1961-01-18 | 1961-01-18 | |
| FR41361A FR1291735A (fr) | 1961-01-18 | 1961-03-15 | Mélange réactionnel à base de chlorure et complexe d'argent à usage agricole et son procédé de fabrication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1492154A1 true DE1492154A1 (de) | 1970-01-29 |
Family
ID=26235489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1962S0100894 Pending DE1492154A1 (de) | 1961-01-18 | 1962-01-17 | Verfahren zur Herstellung eines therapeutsich wertvollen Gemischs von silberhaltigen Komplexen und Chloriden |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3337405A (OSRAM) |
| DE (1) | DE1492154A1 (OSRAM) |
| FR (2) | FR882M (OSRAM) |
| GB (1) | GB965010A (OSRAM) |
| NL (1) | NL126670C (OSRAM) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4528265A (en) * | 1982-05-11 | 1985-07-09 | Becker Robert O | Processes and products involving cell modification |
| JP2590653B2 (ja) * | 1990-11-28 | 1997-03-12 | 松下電器産業株式会社 | 抗菌性複合体、その製造法、それを用いた樹脂およびコ−キング材 |
| US5429819A (en) * | 1992-10-14 | 1995-07-04 | Matsushita Electric Industrial Co., Ltd. | Antiviral composition |
| FR2734721B1 (fr) * | 1995-06-02 | 1997-08-14 | Clarins | Preparation cosmetique de jour activee par la lumiere et destinee a lutter contre le vieillissement cutane |
| CA2225808C (en) * | 1995-06-30 | 2002-12-17 | Christopher C. Capelli | Silver-based pharmaceutical compositions |
| EP0920252A4 (en) * | 1996-08-16 | 2004-08-18 | Christopher C Capelli | ANTIMICROBIAL COMPOSITIONS BASED ON SILVER |
| US6153210A (en) * | 1997-08-14 | 2000-11-28 | Periodontix, Inc. | Use of locally delivered metal ions for treatment of periodontal disease |
| US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
| US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
| US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
| US20030185901A1 (en) | 2000-07-27 | 2003-10-02 | Burrell Robert E. | Methods of treating conditions with a metal-containing material |
| AU7832201A (en) | 2000-07-27 | 2002-02-13 | Nucryst Pharm Corp | Treatment of hyperproliferative skin disorders and diseases |
| US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
| US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
| US20030180379A1 (en) | 2000-07-27 | 2003-09-25 | Burrell Robert E. | Solutions and aerosols of metal-containing compounds |
| US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
| WO2002085299A2 (en) | 2001-04-23 | 2002-10-31 | Nucryst Pharmaceuticals Corp. | Therapeutic treatments using the direct application of antimicrobial metal compositions |
| US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
| US7249438B1 (en) | 2003-06-04 | 2007-07-31 | Weber Arthur P | Electromotive eradication of moss |
| US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3022216A (en) * | 1962-02-20 | Seed disinfection | ||
| US3180721A (en) * | 1965-04-27 | Synergistic herbicidal composition and method | ||
| US3171782A (en) * | 1962-10-24 | 1965-03-02 | Lab De Rech S Experimentales G | Oral compositions comprising lysozyme and vitamin b6 |
| US2248905A (en) * | 1940-11-30 | 1941-07-08 | American Cyanamid Co | Concentrated photographic fixing and hardening sirup |
| US2782121A (en) * | 1954-02-15 | 1957-02-19 | Goldhammer Jerome Stewart | Combined developer and fixer |
| FR1121989A (fr) * | 1955-01-31 | 1956-08-29 | Leonar Werke Ag | Procédé pour l'obtention d'images photographiques |
| US3143459A (en) * | 1958-04-10 | 1964-08-04 | American Cyanamid Co | Nonfoaming wettable powder compositions |
| US3169902A (en) * | 1958-09-10 | 1965-02-16 | Dow Chemical Co | Hortesin antifungal agricultural compositions and method |
| US3143460A (en) * | 1960-02-23 | 1964-08-04 | Chemagro Corp | Method for making pesticide composition of a pesticide-resin mixture coated on granules |
| US3034956A (en) * | 1960-05-16 | 1962-05-15 | Dow Chemical Co | alpha, alpha, alpha-trifuoro-4-nitro-metacresol seed protectants |
| US3081227A (en) * | 1960-06-28 | 1963-03-12 | Ruff R Wimberly | Endodental sterilizing and anesthetizing composition |
| US3035968A (en) * | 1960-08-29 | 1962-05-22 | Sana Silver Corp | Silver ion bactericidal composition |
| US3130034A (en) * | 1960-10-24 | 1964-04-21 | Collier Carbon & Chemical Co | Zinc containing liquid fertilizer |
| US3162576A (en) * | 1961-11-16 | 1964-12-22 | Upjohn Co | Glyceraldehyde as a topical antiinflammatory agent |
| US3184377A (en) * | 1961-12-12 | 1965-05-18 | Chemagro Corp | Method of killing nematodes with thiophosphates |
| US3183073A (en) * | 1962-01-26 | 1965-05-11 | Preston John Miles | Liquid fertilizer |
| US3186824A (en) * | 1962-06-11 | 1965-06-01 | Du Pont | Defoliating and desiccating composition and method |
| US3178345A (en) * | 1964-01-20 | 1965-04-13 | Upjohn Co | Topical steroid composition |
-
1961
- 1961-01-18 FR FR69041127A patent/FR882M/fr not_active Expired
- 1961-03-15 FR FR41361A patent/FR1291735A/fr not_active Expired
-
1962
- 1962-01-08 NL NL273269A patent/NL126670C/xx active
- 1962-01-17 DE DE1962S0100894 patent/DE1492154A1/de active Pending
- 1962-01-18 GB GB1970/62A patent/GB965010A/en not_active Expired
-
1963
- 1963-06-24 US US290227A patent/US3337405A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR882M (OSRAM) | 1961-10-06 |
| GB965010A (en) | 1964-07-29 |
| NL273269A (OSRAM) | 1964-09-10 |
| NL126670C (OSRAM) | 1969-06-16 |
| FR1291735A (fr) | 1962-04-27 |
| US3337405A (en) | 1967-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1492154A1 (de) | Verfahren zur Herstellung eines therapeutsich wertvollen Gemischs von silberhaltigen Komplexen und Chloriden | |
| DE69304092T2 (de) | Knochenersatzwerkstoff und Verfahren zu seiner Herstellung | |
| DE3032481C2 (OSRAM) | ||
| DE2822671C2 (de) | Arzneimittelzubereitung für die Verwendung in der Zahnmedizin | |
| DE3314150C2 (de) | Zahnzement, enthaltend Tanninderivate | |
| DE2932738C2 (de) | Zahnmedizinische Wurzelfüllpaste | |
| DE2113215A1 (de) | Therapeutisches Kompositum | |
| DE2202964A1 (de) | Stabile,milde,nichttoxische,kampferhaltige Zubereitungen fuer die oertliche Behandlung mit entzuendungshemmender,antipruretischer und antibakterieller Wirkung | |
| DD273977A5 (de) | Verfahren zur herstellung eines stomatologischen praeparates | |
| DE2710728C2 (de) | Reagens für die radiologische Abtastung von Organen, Verfahren zu seiner Herstellung und seine Verwendung | |
| DE2327687A1 (de) | Antiseptisches mittel | |
| CH682631A5 (de) | Präparat zur Förderung des Haarwuchses. | |
| DE4315866C1 (de) | Äußerliche Zubereitungen zur Therapie von Hauterkrankungen mit Photosensibilisatoren | |
| DE3624010A1 (de) | Arznei- bzw. heilmittel zur behandlung des ganzheitlichen menschlichen organismus | |
| DE2411971A1 (de) | Salbe zur behandlung von keloiden und brandwunden und verfahren zu deren herstellung | |
| DE3724259A1 (de) | Mittel zur bekaempfung von haarausfall, insbesondere von androgenetischem haarausfall | |
| DE3629385C2 (OSRAM) | ||
| DE3901575C2 (OSRAM) | ||
| AT397612B (de) | Zahnpaste und verfahren zu ihrer herstellung | |
| DE4212057C2 (de) | Zubereitung bestehend aus einer Lösung von Oleanderblättern in Petroleum | |
| DE69422346T2 (de) | Ipriflavone enthaltende pharmazeutische Zubereitungen und deren Verwendung zur Ersetzung von Knochendefekten | |
| DE2011499A1 (de) | Arzneimittel aus Germaniumsäure und Cystein und Verfahren zu seiner Herstellung | |
| DE3447572A1 (de) | Mittel zur regenerierung und staerkung tierischer und menschlicher organismen koerpereigener abwehrkraefte und der haut sowie zu deren schutz aus aloe-wirkstoffen | |
| DE745419C (de) | Verfahren zur Herstellung eines spezifischen Heilmittels gegen Hautekzeme | |
| DE463805C (de) | Verfahren zur Darstellung haltbarer, sterilisierbarer Loesungen, die Phosphor in organischer Bindung sowie gebundenes Gold enthalten |